Constantine Yiannoutsos - Publications

Affiliations: 
1998-2007 Statistics Harvard University, Cambridge, MA, United States 

46 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Desmonde S, Tanser F, Vreeman R, Takassi E, Edmonds A, Lumbiganon P, Pinto J, Malateste K, McGowan C, Kariminia A, Yotebieng M, Dicko F, Yiannoutsos C, Mubiana-Mbewe M, Wools-Kaloustian K, et al. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study. Plos Medicine. 15: e1002565. PMID 29727458 DOI: 10.1371/Journal.Pmed.1002565  0.351
2018 Tymejczyk O, Brazier E, Yiannoutsos C, Wools-Kaloustian K, Althoff K, Crabtree-Ramírez B, Van Nguyen K, Zaniewski E, Dabis F, Sinayobye JD, Anderegg N, Ford N, Wikramanayake R, Nash D. HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries. Plos Medicine. 15: e1002534. PMID 29570723 DOI: 10.1371/Journal.Pmed.1002534  0.303
2018 Vreeman RC, Ayaya SO, Musick BS, Yiannoutsos CT, Cohen CR, Nash D, Wabwire D, Wools-Kaloustian K, Wiehe SE. Adherence to antiretroviral therapy in a clinical cohort of HIV-infected children in East Africa. Plos One. 13: e0191848. PMID 29466385 DOI: 10.1371/Journal.Pone.0191848  0.339
2017 Anderegg N, Johnson LF, Zaniewski E, Althoff KN, Balestre E, Law M, Nash D, Shepherd BE, Yiannoutsos CT, Egger M. All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up. Aids (London, England). 31: S31-S40. PMID 28296798 DOI: 10.1097/Qad.0000000000001321  0.305
2015 Geng EH, Odeny TA, Lyamuya RE, Nakiwogga-Muwanga A, Diero L, Bwana M, Muyindike W, Braitstein P, Somi GR, Kambugu A, Bukusi EA, Wenger M, Wools-Kaloustian KK, Glidden DV, Yiannoutsos CT, et al. Estimation of Mortality among HIV-infected people on antiretroviral therapy treatment in east Africa: a sampling based approach in an observational, multisite, cohort study. The Lancet Hiv. 2: e107-e116. PMID 26120593 DOI: 10.1016/S2352-3018(15)00002-8  0.317
2015 Anderson AM, Harezlak J, Bharti A, Mi D, Taylor MJ, Daar ES, Schifitto G, Zhong J, Alger JR, Brown MS, Singer EJ, Campbell TB, McMahon DD, Buchthal S, Cohen R, ... Yiannoutsos C, et al. Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 69: 29-35. PMID 25622053 DOI: 10.1097/Qai.0000000000000532  0.376
2014 Peterson J, Gisslen M, Zetterberg H, Fuchs D, Shacklett BL, Hagberg L, Yiannoutsos CT, Spudich SS, Price RW. Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection. Plos One. 9: e116081. PMID 25541953 DOI: 10.1371/Journal.Pone.0116081  0.332
2014 Young AC, Yiannoutsos CT, Hegde M, Lee E, Peterson J, Walter R, Price RW, Meyerhoff DJ, Spudich S. Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection. Neurology. 83: 1592-600. PMID 25261502 DOI: 10.1212/Wnl.0000000000000932  0.375
2014 Petersen M, Yiannoutsos CT, Justice A, Egger M. Observational research on NCDs in HIV-positive populations: conceptual and methodological considerations. Journal of Acquired Immune Deficiency Syndromes (1999). 67: S8-16. PMID 25117964 DOI: 10.1097/Qai.0000000000000253  0.338
2014 Petersen ML, Tran L, Geng EH, Reynolds SJ, Kambugu A, Wood R, Bangsberg DR, Yiannoutsos CT, Deeks SG, Martin JN. Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa. Aids (London, England). 28: 2097-107. PMID 24977440 DOI: 10.1097/Qad.0000000000000349  0.307
2014 Harezlak J, Cohen R, Gongvatana A, Taylor M, Buchthal S, Schifitto G, Zhong J, Daar ES, Alger JR, Brown M, Singer EJ, Campbell TB, McMahon D, So YT, Yiannoutsos CT, et al. Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART. Journal of Neurovirology. 20: 294-303. PMID 24696364 DOI: 10.1007/S13365-014-0246-6  0.426
2014 Gold JA, Grill M, Peterson J, Pilcher C, Lee E, Hecht FM, Fuchs D, Yiannoutsos CT, Price RW, Robertson K, Spudich S. Longitudinal characterization of depression and mood states beginning in primary HIV infection. Aids and Behavior. 18: 1124-32. PMID 24385231 DOI: 10.1007/S10461-013-0688-5  0.337
2013 Hua X, Boyle CP, Harezlak J, Tate DF, Yiannoutsos CT, Cohen R, Schifitto G, Gongvatana A, Zhong J, Zhu T, Taylor MJ, Campbell TB, Daar ES, Alger JR, Singer E, et al. Disrupted cerebral metabolite levels and lower nadir CD4 + counts are linked to brain volume deficits in 210 HIV-infected patients on stable treatment. Neuroimage. Clinical. 3: 132-42. PMID 24179857 DOI: 10.1016/J.Nicl.2013.07.009  0.416
2013 Yilmaz A, Yiannoutsos CT, Fuchs D, Price RW, Crozier K, Hagberg L, Spudich S, Gisslén M. Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy. Journal of Neuroinflammation. 10: 62. PMID 23664008 DOI: 10.1186/1742-2094-10-62  0.314
2013 Gongvatana A, Harezlak J, Buchthal S, Daar E, Schifitto G, Campbell T, Taylor M, Singer E, Algers J, Zhong J, Brown M, McMahon D, So YT, Mi D, Heaton R, ... ... Yiannoutsos C, et al. Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy. Journal of Neurovirology. 19: 209-18. PMID 23613008 DOI: 10.1007/S13365-013-0162-1  0.443
2013 Geng EH, Bwana MB, Muyindike W, Glidden DV, Bangsberg DR, Neilands TB, Bernheimer I, Musinguzi N, Yiannoutsos CT, Martin JN. Failure to initiate antiretroviral therapy, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda. Journal of Acquired Immune Deficiency Syndromes (1999). 63: e64-71. PMID 23429504 DOI: 10.1097/QAI.0b013e31828af5a6  0.308
2013 Gelman BB, Lisinicchia JG, Morgello S, Masliah E, Commins D, Achim CL, Fox HS, Kolson DL, Grant I, Singer E, Yiannoutsos CT, Sherman S, Gensler G, Moore DJ, Chen T, et al. Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort. Journal of Acquired Immune Deficiency Syndromes (1999). 62: 487-95. PMID 23242157 DOI: 10.1097/Qai.0B013E31827F1Bdb  0.356
2012 Yiannoutsos CT, Johnson LF, Boulle A, Musick BS, Gsponer T, Balestre E, Law M, Shepherd BE, Egger M. Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy. Sexually Transmitted Infections. 88: i33-43. PMID 23172344 DOI: 10.1136/sextrans-2012-050658  0.314
2011 Geng EH, Hunt PW, Diero LO, Kimaiyo S, Somi GR, Okong P, Bangsberg DR, Bwana MB, Cohen CR, Otieno JA, Wabwire D, Elul B, Nash D, Easterbrook PJ, Braitstein P, ... ... Yiannoutsos CT, et al. Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009. Journal of the International Aids Society. 14: 46. PMID 21955541 DOI: 10.1186/1758-2652-14-46  0.328
2011 Braithwaite RS, Nucifora KA, Yiannoutsos CT, Musick B, Kimaiyo S, Diero L, Bacon MC, Wools-Kaloustian K. Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives? Journal of the International Aids Society. 14: 38. PMID 21801434 DOI: 10.1186/1758-2652-14-38  0.334
2011 Tate DF, Sampat M, Harezlak J, Fiecas M, Hogan J, Dewey J, McCaffrey D, Branson D, Russell T, Conley J, Taylor M, Schifitto G, Schifitto G, Zhong J, Daar ES, ... ... Yiannoutsos C, et al. Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies. Journal of Neurovirology. 17: 368-79. PMID 21556960 DOI: 10.1007/S13365-011-0033-6  0.418
2011 Braitstein P, Songok J, Vreeman RC, Wools-Kaloustian KK, Koskei P, Walusuna L, Ayaya S, Nyandiko W, Yiannoutsos C. "Wamepotea" (they have become lost): outcomes of HIV-positive and HIV-exposed children lost to follow-up from a large HIV treatment program in western Kenya. Journal of Acquired Immune Deficiency Syndromes (1999). 57: e40-6. PMID 21407085 DOI: 10.1097/QAI.0b013e3182167f0d  0.308
2011 Harezlak J, Buchthal S, Taylor M, Schifitto G, Zhong J, Daar E, Alger J, Singer E, Campbell T, Yiannoutsos C, Cohen R, Navia B. Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. Aids (London, England). 25: 625-33. PMID 21297425 DOI: 10.1097/Qad.0B013E3283427Da7  0.356
2011 Letendre SL, Zheng JC, Kaul M, Yiannoutsos CT, Ellis RJ, Taylor MJ, Marquie-Beck J, Navia B. Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals. Journal of Neurovirology. 17: 63-9. PMID 21246320 DOI: 10.1007/S13365-010-0013-2  0.423
2010 Siika AM, Wools-Kaloustian K, Mwangi AW, Kimaiyo SN, Diero LO, Ayuo PO, Owino-Ong'or WD, Sidle JE, Einterz RM, Yiannoutsos CT, Musick B, Tierney WM. Risk factors for death in HIV-infected adult African patients receiving anti-retroviral therapy. East African Medical Journal. 87: 443-51. PMID 23457806  0.308
2010 Cohen RA, Harezlak J, Gongvatana A, Buchthal S, Schifitto G, Clark U, Paul R, Taylor M, Thompson P, Tate D, Alger J, Brown M, Zhong J, Campbell T, Singer E, ... ... Yiannoutsos CT, et al. Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes. Journal of Neurovirology. 16: 435-44. PMID 20961212 DOI: 10.3109/13550284.2010.520817  0.4
2010 Ochieng-Ooko V, Ochieng D, Sidle JE, Holdsworth M, Wools-Kaloustian K, Siika AM, Yiannoutsos CT, Owiti M, Kimaiyo S, Braitstein P. Influence of gender on loss to follow-up in a large HIV treatment programme in western Kenya. Bulletin of the World Health Organization. 88: 681-8. PMID 20865073 DOI: 10.2471/BLT.09.064329  0.311
2010 Geng EH, Glidden DV, Emenyonu N, Musinguzi N, Bwana MB, Neilands TB, Muyindike W, Yiannoutsos CT, Deeks SG, Bangsberg DR, Martin JN. Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa. Tropical Medicine & International Health : Tm & Ih. 15: 63-9. PMID 20586962 DOI: 10.1111/J.1365-3156.2010.02507.X  0.311
2010 Braitstein P, Katshcke A, Shen C, Sang E, Nyandiko W, Ochieng VO, Vreeman R, Yiannoutsos CT, Wools-Kaloustian K, Ayaya S. Retention of HIV-infected and HIV-exposed children in a comprehensive HIV clinical care programme in Western Kenya. Tropical Medicine & International Health : Tm & Ih. 15: 833-41. PMID 20487430 DOI: 10.1111/j.1365-3156.2010.02539.x  0.361
2010 Cohen RA, Harezlak J, Schifitto G, Hana G, Clark U, Gongvatana A, Paul R, Taylor M, Thompson P, Alger J, Brown M, Zhong J, Campbell T, Singer E, Daar E, ... ... Yiannoutsos CT, et al. Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. Journal of Neurovirology. 16: 25-32. PMID 20113183 DOI: 10.3109/13550280903552420  0.405
2009 Schifitto G, Yiannoutsos CT, Ernst T, Navia BA, Nath A, Sacktor N, Anderson C, Marra CM, Clifford DB. Selegiline and oxidative stress in HIV-associated cognitive impairment. Neurology. 73: 1975-81. PMID 19890073 DOI: 10.1212/Wnl.0B013E3181C51A48  0.317
2008 Paul RH, Ernst T, Brickman AM, Yiannoutsos CT, Tate DF, Cohen RA, Navia BA. Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV. Journal of the International Neuropsychological Society : Jins. 14: 725-33. PMID 18764968 DOI: 10.1017/S1355617708080910  0.439
2008 Yiannoutsos CT, Nakas CT, Navia BA. Assessing multiple-group diagnostic problems with multi-dimensional receiver operating characteristic surfaces: application to proton MR Spectroscopy (MRS) in HIV-related neurological injury. Neuroimage. 40: 248-55. PMID 18191586 DOI: 10.1016/J.Neuroimage.2007.09.056  0.416
2007 Paul RH, Yiannoutsos CT, Miller EN, Chang L, Marra CM, Schifitto G, Ernst T, Singer E, Richards T, Jarvik GJ, Price R, Meyerhoff DJ, Kolson D, Ellis RJ, Gonzalez G, et al. Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity. The Journal of Neuropsychiatry and Clinical Neurosciences. 19: 283-92. PMID 17827413 DOI: 10.1176/Appi.Neuropsych.19.3.283  0.508
2007 Schifitto G, Navia BA, Yiannoutsos CT, Marra CM, Chang L, Ernst T, Jarvik JG, Miller EN, Singer EJ, Ellis RJ, Kolson DL, Simpson D, Nath A, Berger J, Shriver SL, et al. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. Aids (London, England). 21: 1877-86. PMID 17721095 DOI: 10.1097/Qad.0B013E32813384E8  0.478
2006 Schifitto G, Yiannoutsos CT, Simpson DM, Marra CM, Singer EJ, Kolson DL, Nath A, Berger JR, Navia B. A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy. Journal of Neurovirology. 12: 328-31. PMID 16966223 DOI: 10.1080/13550280600873835  0.338
2006 Wools-Kaloustian K, Kimaiyo S, Diero L, Siika A, Sidle J, Yiannoutsos CT, Musick B, Einterz R, Fife KH, Tierney WM. Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. Aids (London, England). 20: 41-8. PMID 16327318  0.342
2005 Ellis RJ, Evans SR, Clifford DB, Moo LR, McArthur JC, Collier AC, Benson C, Bosch R, Simpson D, Yiannoutsos CT, Yang Y, Robertson K. Clinical validation of the NeuroScreen. Journal of Neurovirology. 11: 503-11. PMID 16338744 DOI: 10.1080/13550280500384966  0.367
2004 Chang L, Lee PL, Yiannoutsos CT, Ernst T, Marra CM, Richards T, Kolson D, Schifitto G, Jarvik JG, Miller EN, Lenkinski R, Gonzalez G, Navia BA. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age. Neuroimage. 23: 1336-47. PMID 15589098 DOI: 10.1016/J.Neuroimage.2004.07.067  0.537
2004 Yiannoutsos CT, Ernst T, Chang L, Lee PL, Richards T, Marra CM, Meyerhoff DJ, Jarvik JG, Kolson D, Schifitto G, Ellis RJ, Swindells S, Simpson DM, Miller EN, Gonzalez RG, et al. Regional patterns of brain metabolites in AIDS dementia complex. Neuroimage. 23: 928-35. PMID 15528093 DOI: 10.1016/J.Neuroimage.2004.07.033  0.464
2003 Lee PL, Yiannoutsos CT, Ernst T, Chang L, Marra CM, Jarvik JG, Richards TL, Kwok EW, Kolson DL, Simpson D, Tang CY, Schifitto G, Ketonen LM, Meyerhoff DJ, Lenkinski RE, et al. A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis. Journal of Magnetic Resonance Imaging : Jmri. 17: 625-33. PMID 12766890 DOI: 10.1002/Jmri.10295  0.407
2001 Simpson DM, Katzenstein D, Haidich B, Millington D, Yiannoutsos C, Schifitto G, McArthur J. Plasma carnitine in HIV-associated neuropathy. Aids (London, England). 15: 2207-8. PMID 11684949 DOI: 10.1097/00002030-200111090-00025  0.308
1999 Price RW, Yiannoutsos CT, Clifford DB, Zaborski L, Tselis A, Sidtis JJ, Cohen B, Hall CD, Erice A, Henry K. Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team. Aids (London, England). 13: 1677-85. PMID 10509569 DOI: 10.1097/00002030-199909100-00011  0.318
1999 Clifford DB, Yiannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero PJ, Marra CM, Francis GS, McArthur JC, Tyler KL, Tselis AC, Hyslop NE. Haart improves prognosis in HIV-associated progressive multifocal leukoencephalopathy Neurology. 52: 623-625. PMID 10025799 DOI: 10.1212/Wnl.52.3.623  0.379
1998 Cinque P, Casari S, Bertelli D, Hall CD, Yiannoutsos C, Clifford DB. Progressive multifocal leukoencephalopathy, HIV, and highly active antiretroviral therapy [4] (multiple letters) New England Journal of Medicine. 339: 848-849. PMID 9750081 DOI: 10.1056/NEJM199809173391216  0.333
1998 Navia BA, Dafni U, Simpson D, Tucker T, Singer E, McArthur JC, Yiannoutsos C, Zaborski L, Lipton SA. A phase I/II trial of nimodipine for HIV-related neurologic complications. Neurology. 51: 221-8. PMID 9674806 DOI: 10.1212/Wnl.51.1.221  0.343
Show low-probability matches.